The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Estrogen in Severe Mental Illness: A Potential New Treatment Approach
Abstract
CONTEXT: Accumulating evidence suggests that estrogens may have therapeutic effects in severe mental illnesses, including schizophrenia, via neuromodulatory and neuroprotective activity. OBJECTIVE: To compare the efficacy of adjunctive transdermal estradiol with that of adjunctive placebo in the treatment of acute psychotic symptoms. DESIGN: Randomized, double-blind study. SETTING: Patients were recruited from inpatient acute hospital wards and outpatient clinics of 2 metropolitan Melbourne general hospitals. PARTICIPANTS: One hundred two women of childbearing age with schizophrenia. All participants were in an acute or chronic phase of their illness; 73 participants were outpatients and the rest were inpatients. Intervention Patients were randomized to receive 100 microg of transdermal estradiol (n = 56) or transdermal placebo (n = 46) for 28 days. MAIN OUTCOME MEASURES: Psychopathological symptoms were assessed weekly with the Positive and Negative Syndrome Scale. RESULTS: The addition of 100 microg of transdermal estradiol significantly reduced positive (P < .05) and general psychopathological (P < .05) symptoms during the 28-day trial period compared with women receiving antipsychotic medication alone. CONCLUSION: Estradiol appears to be a useful treatment for women with schizophrenia and may provide a new adjunctive therapeutic option for severe mental illness. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00206570.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
(1976) · Medical Entomology and Zoology · Cited by 8,899
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., Cooper, J. E., Day, R., & Bertelsen, A. (1992) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100000904 · Cited by 1,769
Epidemiology of Puerperal Psychoses
Kendell, R. E., Chalmers, J. C., & Platz, C. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.150.5.662 · Cited by 1,119
Garcia-Segura, L. M., Azcoitia, I., & DonCarlos, L. L. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00025-3 · Cited by 938
de Novaes Soares, C., Almeida, O. P., Joffe, H., & Cohen, L. S. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.529 · Cited by 691
Invited Review: Estrogens effects on the brain: multiple sites and molecular mechanisms
McEwen, B. S. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.6.2785 · Cited by 659
Gender differences in schizophrenia
Häfner, H. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00125-7 · Cited by 565
Transdermal oestrogen for treatment of severe postnatal depression
Gregoire, A. J. P., Kumar, R., Everitt, B., & Studd, J. W. W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91414-2 · Cited by 562
Psychopathology in Women and Men: Focus on Female Hormones
Seeman, M. V. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.12.1641 · Cited by 534
Diverse Actions of Ovarian Steroids in the Serotonin Neural System
Bethea, C. L., Lu, N. Z., Gundlah, C., & Streicher, J. M. (2002) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0225 · Cited by 490
Häfner, H., & an der Heiden, W. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200204 · Cited by 436
Gender differences in age at onset of Schizophrenia: An Overview
Angermeyer, M. C., & K�hnz, L. (1988) · European Archives of Psychiatry and Neurological Sciences · doi:10.1007/bf00380979 · Cited by 312
Estrogen Receptor Gene Expression in Relation to Neuropsychiatric Disorders
ÖSTLUND, H., KELLER, E., & HURD, Y. L. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1286.006 · Cited by 285
Effect of Estrogen-Serotonin Interactions on Mood and Cognition
Amin, Z., Canli, T., & Epperson, C. N. (2005) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582305277152 · Cited by 227
Estrogen — a potential treatment for schizophrenia
Kulkarni, J., Riedel, A., de Castella, A. R., Fitzgerald, P. B., Rolfe, T. J., Taffe, J., & Burger, H. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00088-8 · Cited by 225
Self-citationCornil, C. A., Ball, G. F., & Balthazart, J. (2006) · Brain Research · doi:10.1016/j.brainres.2006.07.098 · Cited by 223
Current outcome in schizophrenia: women vs men
Seeman, M. V. (1986) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1986.tb02732.x · Cited by 209
Häfner, H., Riecher-Rössler, A., Maurer, K., Fätkenheuer, B., & Löffler, W. (1992) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02191557 · Cited by 190
Treatment of Schizophrenia Negative Symptoms: Future Prospects
Erhart, S. M., Marder, S. R., & Carpenter, W. T. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj055 · Cited by 185
A clinical trial of the effects of estrogen in acutely psychotic women
Kulkarni, J., de Castella, A., Smith, D., Taffe, J., Keks, N., & Copolov, D. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(96)82949-5 · Cited by 160
Self-citationSchizophrenia and oestrogens — is there an association?
Riecher-Rössler, A., & Häfner, H. (1993) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190244 · Cited by 159
Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson’s disease
Cyr, M., Calon, F., Morissette, M., & Paolo, T. D. (2002) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0202 · Cited by 148
Akhondzadeh, S., Nejatisafa, A., Amini, H., Mohammadi, M. R., Larijani, B. A., Kashani, L., Raisi, F., & Kamalipour, A. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00161-1 · Cited by 148
Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia
Bergemann, N., Parzer, P., Runnebaum, B., Resch, F., & Mundt, C. (2007) · Psychological Medicine · doi:10.1017/s0033291707000578 · Cited by 134
Kritzer, M. F., & Kohama, S. G. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990705)409:3<438::aid-cne8>3.0.co;2-5 · Cited by 127
Inhibition of striatal dopamine transporter activity by 17β-estradiol
Disshon, K. A., Boja, J. W., & Dluzen, D. E. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00008-9 · Cited by 108
Estrogen as Neuroprotectant of Nigrostriatal Dopaminergic System: Laboratory and Clinical Studies
Dluzen, D. E., & Horstink, M. W. I. M. (2003) · Endocrine · doi:10.1385/endo:21:1:67 · Cited by 105
Neuroprotective activities of estrogen: An update
Behl, C., & Manthey, D. (2000) · Journal of Neurocytology · doi:10.1023/a:1007109222673 · Cited by 104
Hormones and depression in women
Studd, J. W. W., & Panay, N. (2004) · Climacteric · doi:10.1080/13697130400012262 · Cited by 102
Further evidence for a specific role of estradiol in schizophrenia?
Riecher‐Rössler, A., Häfner, H., Dütsch-Strobel, A., Oster, M., Stumbaum, M., van Gülick-Bailer, M., & Löffler, W. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90649-1 · Cited by 96
Estrogen can protect neurons: modes of action
Behl, C. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00271-6 · Cited by 94
Validation of Danish case register diagnosis for schizophrenia
Löffler, W., Häfner, H., Fätkenheuer, B., Maurer, K., Riecher‐Rössler, A., Lützhøft, J. H., Skadhede, S., Munk‐Jørgensen, P., & Strömgren, E. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01577.x · Cited by 93
Huber, T. J., Tettenborn, C., Leifke, E., & Emrich, H. M. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.05.010 · Cited by 91
Chua, W. L. L., de Santiago, A. I., Kulkarni, J., & Mortimer, A. M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004719.pub2 · Cited by 74
Self-citationChang, S.-W., & Renshaw, D. C. (1986) · PubMed · Cited by 69
Clinical Pharmacology and Differential Cognitive Efficacy of Estrogen Preparations
Gleason, C. E., Carlsson, C. M., Johnson, S. C., Atwood, C., & Asthana, S. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1347.007 · Cited by 63
A clinical trial of adjunctive oestrogen treatment in women with schizophrenia
Kulkarni, J., Riedel, A., de Castella, A. R., Fitzgerald, P. B., Rolfe, T., Taffe, J. R., & Burger, H. (2002) · Archives of Women s Mental Health · doi:10.1007/s00737-002-0001-5 · Cited by 62
Self-citationChronic estrogen treatment replaces striatal dopaminergic function in ovariectomized rats
Ohtani, H., Nomoto, M., & Douchi, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02276-4 · Cited by 61
Anderson, G. M., Connors, J. M., Hardy, S. L., Valent, M., & Goodman, R. L. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00726.x · Cited by 54
Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor
Landry, M., & Paolo, T. D. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00049-4 · Cited by 45
An Update on Estrogen: Higher Cognitive Function, Receptor Mapping, Neurotrophic Effects
Taber, K. H., Murphy, D. D., Blurton-Jones, M. M., & Hurley, R. A. (2001) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13.3.313 · Cited by 25
Cited by
Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O., & Tran, N. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416641195 · Cited by 877
Self-citationMiyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders
Pinares-Garcia, P., Stratikopoulos, M., Zagato, A., Loke, H., & Lee, J. (2018) · Brain Sciences · doi:10.3390/brainsci8080154 · Cited by 200
Jeppesen, R., Christensen, R. H. B., Pedersen, E. M. J., Nordentoft, M., Hjorthøj, C., Köhler-Forsberg, O., & Benros, M. E. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.08.028 · Cited by 132
Gender Differences in Individuals at High‐Risk of Psychosis: A Comprehensive Literature Review
Barajas, A., Ochoa, S., Obiols, J. E., & Lalucat-Jo, L. (2015) · The Scientific World Journal · doi:10.1155/2015/430735 · Cited by 122
Metadata
- Authors
- Kulkarni, J., de Castella, A., Fitzgerald, P. B., Gurvich, C. T., Bailey, M., Bartholomeusz, C., & Burger, H.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2008-08-04
- Volume
- 65
- Issue
- 8
- Pages
- 955
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2044301098
- Cited by
- 254
- References
- 44
- FWCI
- 14.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.